Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Ambrx Biopharma Cayman, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ambrx Biopharma Cayman, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ambrx Biopharma Cayman, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Ambrx Biopharma Cayman, Inc.
CIK:
0001836056
|
SEC Filings
INDENTURES
EX-4.2
d185729dex42.htm
2021-06-22T00:00:00Z
EX-4.4
d185729dex44.htm
2021-06-22T00:00:00Z
EX-4.4
d108474dex44.htm
2021-06-14T00:00:00Z
EX-4.1
d108474dex41.htm
2021-06-14T00:00:00Z
EX-4.4
d108474dex44.htm
2021-05-28T00:00:00Z
EX-4.2
d108474dex42.htm
2021-05-28T00:00:00Z
EX-4.4
amam-ex4_4.htm
2023-08-09T00:00:00Z
EX-4.3
amam-ex4_3.htm
2023-08-09T00:00:00Z
EX-4.4
filename3.htm
2021-02-03T00:00:00Z